Unique: Pangaea Information, AstraZeneca’s Alexion accomplice to identify uncommon illness with EHRs
Pangaea Data, a company focused on detecting hard-to-diagnose diseases in patients, is partnering with Alexion, a subsidiary of AstraZeneca focused on treating rare diseases, to co-develop, clinically validate and ultimately seek regulatory approval for an AI-enabled offering to detect hypophosphatasia in adults. “Alexion entered into a multi-collaboration agreement with Pangaea a few months ago, which has … Read more
